Search results
BioNTech says 90% of 2024 revenues will accrue at end of year
WHTC 1450 Holland· 5 days agoFRANKFURT (Reuters) - Germany's BioNTech, whose COVID-19 vaccine in partnership with Pfizer was...
BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 5 days agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost all of its expected 2024 revenues would ...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 12 hours agoNovavax struggled after its COVID-19 vaccine was delayed by manufacturing issues early in...
Kestra Private Wealth Services LLC Buys New Position in BioNTech SE (NASDAQ:BNTX)
ETF DAILY NEWS· 6 days agoKestra Private Wealth Services LLC bought a new stake in shares of BioNTech SE (NASDAQ:BNTX – Free Report) in the 4th quarter, according to the company in its most recent ...
Cracking The Code: Understanding Analyst Reviews For BioNTech - BioNTech (NASDAQ:BNTX)
Benzinga· 4 days agoLoading... Loading... Throughout the last three months, 12 analysts have evaluated BioNTech BNTX , offering a diverse set of opinions from bullish to bearish. The table below ...
BioNTech shares dip 2% on earnings and revenue miss By Investing.com
Investing.com· 5 days agoShares of BioNTech SE (NASDAQ:BNTX) fell 2.2% following the announcement of the first quarter...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 18 hours ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Q1 2024 BioNTech SE Earnings Call Transcript
Guru Focus· 5 days agoThank you for joining BioNTech's First Quarter 2024 Earnings Call. As a reminder, the slides we will be using on this call and the corresponding press release published this ...
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
RTT News· 5 days agoGerman Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a loss in its first quarter, compared to prior year's profit with sharply ...
BioNTech's Outlook Gives Vaccine Maker a Shot in the Arm
Investopedia· 5 days agoAmerican depositary receipts (ADRs) of BioNTech (BNTX) were down less than 1% in intraday trading...